Cargando…
Comparison of the effect of recombinant human pro-urokinase and tirofiban on myocardial blood flow perfusion in ST elevation myocardial infarction patients receiving primary percutaneous coronary intervention: A one-center retrospective observational study
Ischemia/reperfusion (I/R) injury is associated with primary percutaneous coronary intervention (PPCI). The current study was performed to compare the effect of tirofiban and recombinant human pro-urokinase (rh-proUK) on the improvement of coronary slow blood after PPCI. Sixty-five ST elevation myoc...
Autores principales: | Yao, Zhuhua, Li, Wenting, Cheng, Lisong, Cao, Mingying, Pang, Zhihua, Li, Yongbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6635167/ https://www.ncbi.nlm.nih.gov/pubmed/31277114 http://dx.doi.org/10.1097/MD.0000000000016143 |
Ejemplares similares
-
Influences of different dose of tirofiban for acute ST elevation myocardial infarction patients underwent percutaneous coronary intervention
por: Wang, Haixia, et al.
Publicado: (2020) -
Effects of Intracoronary Pro-urokinase or Tirofiban on Coronary Flow During Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction: A Multi-Center, Placebo-Controlled, Single-Blind, Randomized Clinical Trial
por: Huang, Dong, et al.
Publicado: (2021) -
Influence of Tirofiban maintenance duration on patients with acute myocardial infarction treated by percutaneous coronary intervention
por: Ji, Zhen-Guo, et al.
Publicado: (2015) -
Subacute Myocardial Rupture Following Tirofiban Treatment
por: Çiftçi, Özgür, et al.
Publicado: (2013) -
Tirofiban usage and prognosis after myocardial infarction
por: Eyüboğlu, Mehmet
Publicado: (2016)